Patents by Inventor Anu Daniel

Anu Daniel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Chimeric bacteriophage lysin with activity against bacteria
    Patent number: 11827911
    Abstract: The present description relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. Aureus and VISA.
    Type: Grant
    Filed: May 24, 2021
    Date of Patent: November 28, 2023
    Assignee: The Rockefeller University
    Inventors: Vincent A Fischetti, Anu Daniel, Chad Euler
  • CHIMERIC BACTERIOPHAGE LYSIN WITH ACTIVITY AGAINST STAPHYLOCOCCI BACTERIA
    Publication number: 20210348146
    Abstract: The present description relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. Aureus and VISA.
    Type: Application
    Filed: May 24, 2021
    Publication date: November 11, 2021
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler
  • Chimeric bacteriophage lysin with activity against staphylococci bacteria
    Patent number: 11015182
    Abstract: The present disclosure relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. aureus (MRSA) and vancomycin intermediate S. aureus (VISA).
    Type: Grant
    Filed: August 20, 2018
    Date of Patent: May 25, 2021
    Assignee: The Rockefeller University
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler
  • CHIMERIC BACTERIOPHAGE LYSIN WITH ACTIVITY AGAINST STAPHYLOCOCCI BACTERIA
    Publication number: 20190055533
    Abstract: The present disclosure relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. Aureus and VISA.
    Type: Application
    Filed: August 20, 2018
    Publication date: February 21, 2019
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler
  • Chimeric bacteriophage lysin with activity against staphylococci bacteria
    Patent number: 10053681
    Abstract: The present disclosure relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. Aureus and VISA.
    Type: Grant
    Filed: September 9, 2014
    Date of Patent: August 21, 2018
    Assignee: THE ROCKEFELLER UNIVERSITY
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler
  • CHIMERIC BACTERIOPHAGE LYSIN WITH ACTIVITY AGAINST STAPHYLOCOCCI BACTERIA
    Publication number: 20150064156
    Abstract: The present disclosure relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. Aureus and VISA.
    Type: Application
    Filed: September 9, 2014
    Publication date: March 5, 2015
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler
  • Chimeric bacteriophage lysin with activity against bacteria
    Patent number: 8840900
    Abstract: The present disclosure relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. aureus (MRSA) and vancomycin-resistant Staphylococcus aureus (VISA).
    Type: Grant
    Filed: July 1, 2009
    Date of Patent: September 23, 2014
    Assignee: The Rockefeller University
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler
  • CHIMERIC BACTERIOPHAGE LYSIN WITH ACTIVITY AGAINST STAPHYLOCOCCI BACTERIA
    Publication number: 20120258088
    Abstract: The present disclosure relates to chimeric bacteriophage lysins useful for the identification and/or reduction of staphylococcal populations. For example, a chimeric bacteriophage lysin was engineered and shown to effectively kill all strains of staphylococci tested including antibiotic resistant methicillin-resistant S. Aureus and VISA.
    Type: Application
    Filed: July 1, 2009
    Publication date: October 11, 2012
    Inventors: Vincent A. Fischetti, Anu Daniel, Chad Euler